AMSA Pharm-free Scorecard 2010
B Texas A&M Health Science Center College of Medicine
City: College Station State: TX
Links:
Commentary:

Summary: For the 2012-3 evaluation, Texas A&M Health Science Center College of Medicine submitted updated policies. Model policies are enacted in areas related to gifts, with the prohibition of all gifts and on-site meals. Model policies exist for both on-site and off-site education and industry-sponsored scholarships, which require no involvement from industry in the selection of the scholarship recipient. Yet, the institution could improve by mandating formal contracts, along with institutional review or pre-approval for consulting relationships and requiring purchasing committee members to not only disclose their financial conflicts of interest, but to also recuse themselves from all decisions regarding a company of interest. The policy also now mandates public disclosure upon request. Overall, this institution is moving in the right direction, with oversight and clear sanctions for noncompliance.

Demographics: On average students spend 45% of their training at Scott & White Memorial Hospital, 15% at St. Joseph Healthcare , 10% at The Carl R. Darnall Army Hospital, 10% at St. David’s Hospital, and 20% at Seton and Dell Children’s and Driscoll Children’s Hospital. Polices were submitted all of these sites except for the children’s hospitals.

Updates: This institution submitted updated policies to the 2012-3 AMSA PharmFree Scorecard, their score remains a B.

 

This institution's evaluation was last updated: 4/9/2013.



Gifts & Meals 3 The policy prohibits gifts and on-site meals.
Consulting relationships 2 The policy requires institutional pre-approval of consulting relationships.
Industry-funded speaking relationships 2 The policy requires pre-approval of participation in "speaker's bureaus" and compensation at fair market value.
Disclosure 3 All personnel are required to disclose conflicts of interest on an annual basis. Policy requires disclosure to public upon request
Pharmaceutical samples 2 The policy clearly states that samples may not be received or delivered to hospitals and are limited to a non-patient-care area in medical office buildings and outlying clinics.
Purchasing & Formularies 2 Committee members are required to disclose their financial conflicts of interest for institutional review and approval.
Industry Sales Representatives 2 Industry representatives are permitted site access only by invitation and appointment.
On-campus Education 3 The central fund for all contributions is the Corporate Division of the Development Office and the donor industry will have no involvement in the distribution of funds.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 The policy explicitly prohibits the receipt of payment for attendance at off-site lectures and payment for travel expenses requires institutional pre-approval.
Industry Support for Scholarships & Funds for Trainees 3 The policy mandates no involvement from the donor industry in the distribution of funds.
Medical school curriculum 3 The institution's curriculum promotes an understanding of financial conflicts of interest, drug and device development
Do the policies specify an oversight mechanism? Yes Oversight is directed.
Are there explicit sanctions for noncompliance? Yes Sanctions referenced.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)